Fundz
Real-time · AI · Cross-signal

Cambium just raised. Here's exactly what to do next.

Who to reach, what to say, and why now — on Cambium, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.
✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.
✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.
✕Clay enriches lists you built — No live signal of its own, no who or when.
✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.
Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Cambium Biomaterials raises $100M in Series B funding led by 8VC to accelerate product pipeline and manufacturing across various sectors.

PRIVATEJan 05, 2026•5 months ago

Amount Raised

$100 Million

Round Type

SERIES B

El SegundoManufacturing

Investors

Jackson MosesJacs CapitalInevitable VenturesGaingelsAlumni VenturesVanderbilt UniversityJ17 VenturesVeteran Ventures CapitalGs BackersLockheed Martin VenturesMvp Ventures8 Vc

Description

Cambium Biomaterials, an El Segundo, CA-based developer of advanced materials, raised $100M in Series B financing. Led by 8VC, the round included participation from numerous investors. The funds will be used to accelerate its product pipeline and manufacturing in the U.S. and Europe

Company Information

Company

Cambium

Location

El Segundo, California, United States

About

Cambium is redefining how advanced materials are discovered, designed, and manufactured. The company develops next-generation advanced materials for defense dual-use applications that enhance performance and survivability across land, air, sea, and space. Cambium's proprietary materials platform molecularly re-engineers polymers from first principles, combining AI-driven molecular design with state-of-the-art chemistry, materials science, and biology. The result is exceptional performance, manufacturability, and speed from concept to production. Manufacturing is carried out through a secure, flexible, and scalable domestic supply chain, enabling defense and commercial innovators to move from prototype to full-scale production in record time.

Related People

Suggested for you
2 contacts

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Cambium's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching Cambium? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan